Volumen | 1.108.019 |
|
|||||
News | - | ||||||
Tageshoch | 13,93 | Niedrig Hoch |
|||||
Tagestief | 12,95 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Day One Biopharmaceuticals Inc | DAWN | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
13,77 | 12,95 | 13,93 | 13,27 | 13,60 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
11.664 | 1.108.019 | US$ 13,46 | US$ 14.918.920 | - | 9,67 - 18,0699 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
23:04:45 | 47 | US$ 13,27 | USD |
Finanzwerte DAWN
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
1,16B | 87,38M | - | 0 | -188,92M | -2,16 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Day One Biopharmaceuticals
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
30.5.2024 | 14:35 | Edgar (US Regulatory) | Form 8-K - Current report |
29.5.2024 | 00:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
24.5.2024 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
18.5.2024 | 00:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
18.5.2024 | 00:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
17.5.2024 | 00:34 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
17.5.2024 | 00:21 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
15.5.2024 | 00:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
06.5.2024 | 22:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06.5.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
07.3.2024 | 22:19 | Edgar (US Regulatory) | Form 8-K - Current report |
29.2.2024 | 01:55 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Day One Biopharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
DAWN Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 13,96 | 14,17 | 12,95 | 13,65 | 933.712 | -0,69 | -4,94% |
1 Monat | 18,00 | 18,00 | 12,95 | 15,48 | 805.420 | -4,73 | -26,28% |
3 Monate | 15,79 | 18,0699 | 12,95 | 15,34 | 1.138.275 | -2,52 | -15,96% |
6 Monate | 11,82 | 18,0699 | 11,30 | 15,08 | 823.753 | 1,45 | 12,27% |
1 Jahr | 12,09 | 18,0699 | 9,67 | 13,78 | 906.770 | 1,18 | 9,76% |
3 Jahre | 23,70 | 28,699 | 5,44 | 15,53 | 678.506 | -10,43 | -44,01% |
5 Jahre | 25,00 | 28,699 | 5,44 | 15,56 | 679.084 | -11,73 | -46,92% |